Yüklüyor......
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism
CDC-like kinase 3 (CLK3) is a dual specificity kinase that functions on substrates containing serine/threonine and tyrosine. But its role in human cancer remains unknown. Herein, we demonstrated that CLK3 was significantly up-regulated in cholangiocarcinoma (CCA) and identified a recurrent Q607R som...
Kaydedildi:
| Yayımlandı: | J Exp Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Rockefeller University Press
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7398168/ https://ncbi.nlm.nih.gov/pubmed/32453420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20191779 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|